Barings’s Acadia Healthcare ACHC Stock Holding History

Barings’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-42,352	Closed	-$1.38M	–	908
2017 Q4	$1.38M	Buy	+42,352	New	+$1.47M	0.02%	475
2017 Q2	–	Sell	-59,455	Closed	-$2.59M	–	842
2017 Q1	$2.59M	Buy	+59,455	New	+$2.41M	0.03%	522

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Barings's ACHC Position: Q1 2018 in Review

Barings sold out of Acadia Healthcare (ACHC) in Q1 2018, closing a stake of 42,352 shares — an estimated $1.38M sold.

Barings first reported a position in ACHC in Q1 2017 and held it in 2 quarters. The position peaked at $2.59M in Q1 2017. 241 funds tracked by Wall St. Rank hold ACHC as of Q1 2018.

Barings reported no remaining Acadia Healthcare position as of Q1 2018 after selling out during the quarter.
Barings sold 42,352 Acadia Healthcare shares in Q1 2018, an estimated $1.38M.
Barings first reported a position in Acadia Healthcare in Q1 2017 and held it in 2 quarters.
Barings's Acadia Healthcare position peaked at $2.59M in Q1 2017.
241 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2018.

Based on Barings's 13F filing for Q1 2018, filed 4 May 2018.